To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

We recently published 10 Stocks with Outstanding Gains; 9 on Record Highs. Indivior PLC (NASDAQ:INDV) is one of the best-performing stocks on Thursday. Indivior climbed for a third straight day on Thursday to reach a new all-time high, as investors cheered a stellar earnings performance and a highly optimistic business outlook for the rest of the year. At intra-day trade, the stock soared to its highest 52-week price of $30.55 before paring gains to end the day just up by 15.41 percent at $29.13 apiece. ...

Risk runs high, but so does the upside. Biotech investing thrives on bold bets and breakthrough data. On October 30, 2025, a wave of clinical-stage and commercial biopharma stocks surged to new 52-week highs, driven by breakthrough trial data, strategic deals, and earnings surprises. From obesity and CNS therapies to rare disease advances and acquisition drama, these moves reflect more than momentum; they signal conviction. Do you have these names on your watchlist? And more importantly, will they keep cli ...

收入和利润 - 2025年第三季度净收入为3.14亿美元，同比增长2%（700万美元）；前九个月净收入为8.81亿美元，同比下降1%（800万美元）[128] - 2025年第三季度毛利率为73%，同比下降6个百分点；前九个月毛利率为80%，同比持平[133][135] 主要产品SUBLOCADE表现 - SUBLOCADE在2025年第三季度贡献了净收入的70%（2.19亿美元），同比增长15%；前九个月贡献了69%（6.04亿美元），同比增长8%[120][128] - 2025年第三季度美国市场SUBLOCADE净收入为2.03亿美元，同比增长14%；前九个月为5.61亿美元，同比增长7%[128][129] 成本和费用 - 2025年第三季度销售、一般及行政费用为1.55亿美元，同比增长9%；前九个月为4.45亿美元，同比增长2%[133][136] - 2025年第三季度研发费用为3300万美元，同比增长48%，部分原因是行动议程相关的1300万美元重组和减值成本[133][137][138] - 2025年九个月的资本支出为4200万美元，相比2024年同期的1300万美元增长了223%[154] 管理层讨论和指引 - 公司计划优化全球其他地区业务并退出多个市场，预计将产生3000万至5000万美元费用，这些市场占预测收入的77%[124][125] - 公司预计2025年全年资本支出在4500万至5500万美元之间，2026年预计为3500万至4500万美元[149] 一次性及重组相关项目 - 公司因停止OPVEE的销售和市场支持，在2025年第三季度确认了3700万美元成本，包括库存和无形资产减记[123][134] - 作为Indivior行动议程第一阶段的一部分，公司在2025年第三季度确认了3500万美元相关成本，包括裁员遣散费和咨询费用[122] 现金流状况 - 2025年九个月的经营活动净现金流入为1.94亿美元，相比2024年同期的5300万美元大幅增加1.41亿美元[145][146] - 2025年九个月的投资活动净现金流出为4200万美元，而2024年同期为净流入6100万美元，变化达1.03亿美元[145][148] - 2025年九个月的融资活动净现金流出为2500万美元，相比2024年同期的1.42亿美元减少了1.17亿美元[145][150] - 公司现金及现金等价物从2024年12月31日的3.19亿美元增至2025年9月30日的4.45亿美元[144] 其他财务数据 - 截至2025年9月30日，应计回扣、产品退货和及时付款折扣余额为6.16亿美元，较2024年同期增加800万美元[132] - 净利息支出在2025年九个月期间为2300万美元，相比2024年同期的1000万美元增长了130%[139] - 2025年九个月的有效税率为32%，而三个月期间的有效税率为14%[140] - 2025年九个月的所得税费用为5000万美元，而2024年同期为所得税收益400万美元[140] - 截至2025年9月30日，公司流动负债超过流动资产4300万美元，总负债超过总资产2.07亿美元[152]

PresentationHello, everyone, and thank you for joining us today for the PTSB conference call. My name is Sami, and I'll be coordinating your call today. [Operator Instructions] I'll now hand over to our host, Eamonn Crowley, CEO, to begin. Please go ahead, Eamonn.Eamonn CrowleyCEO & Executive Director Great. Good morning, everyone, and thank you for joining the call. I'm joined here with our CFO, Barry D'Arcy, and there are 3 topics which we would like to cover with you in the next half hour. First, we anno ...

Key Points Indivior is already profitable and cash-generative, and is set to grow significantly in 2026. Its key medication's delivery system offers opioid use disorder patients more reliable outcomes. 10 stocks we like better than Indivior Plc › Shares in Indivior Plc (NASDAQ: INDV) were up by 15.5% at 1 p.m. ET today after management released an excellent set of third-quarter results, upgraded its full-year guidance, and served notice that its "Indivior Action Agenda" three-phase plan is generati ...

Indivior PLC (INDV) came out with quarterly earnings of $0.72 per share, beating the Zacks Consensus Estimate of $0.38 per share. This compares to earnings of $0.54 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +89.47%. A quarter ago, it was expected that this company would post earnings of $0.26 per share when it actually produced earnings of $0.51, delivering a surprise of +96.15%.Over the last four quarters, the company h ...

Indivior (NasdaqGS:INDV) Q3 2025 Earnings Call October 30, 2025 08:00 AM ET Speaker5Good day and thank you for standing by. Welcome to the Indivior plc Q3 results 2025 webcast and conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star one and one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw ...

业绩总结 - 2025年第三季度总净收入为3.14亿美元，同比增长2%[30] - 2025年第三季度SUBLOCADE净收入为1.05亿美元，同比增长15%[30] - 2025年第三季度调整后EBITDA为1.20亿美元，同比增长14%[30] - 2025年第三季度非GAAP毛利为2.63亿美元，同比增长5%[30] - 2025年第三季度非GAAP毛利率为84%，较去年同期提升251个基点[30] - 2025年第三季度GAAP净收入为42百万美元，较2024年同期的22百万美元上升90.9%[61] - 2025年第三季度非GAAP净收入为93百万美元，较2024年同期的65百万美元上升43.1%[61] 未来展望 - 2025年总净收入指导范围提高至10.80亿至12.20亿美元，较之前指导增加1%[34] - 2025年SUBLOCADE净收入指导范围提高至8.25亿至8.45亿美元，较之前指导增加10%[34] - 2025年调整后EBITDA指导范围提高至4亿至4.20亿美元，较之前指导增加15%[34] - 预计2026年将实现至少1.5亿美元的非GAAP运营费用节省[35] 成本与费用 - 2025年第三季度GAAP运营费用为187百万美元，较2024年同期的206百万美元下降9.2%[49] - 2025年第三季度非GAAP运营费用为145百万美元，较2024年同期的150百万美元下降3.3%[49] - 2025年第三季度GAAP一般和行政费用为94百万美元，较2024年同期的87百万美元上升8.0%[51] - 2025年第三季度非GAAP一般和行政费用为71百万美元，较2024年同期的81百万美元下降12.3%[51] - 2025年第三季度GAAP销售和营销费用为62百万美元，较2024年同期的55百万美元上升12.7%[53] - 2025年第三季度非GAAP销售和营销费用为56百万美元，较2024年同期的46百万美元上升21.7%[53] - 2025年第三季度GAAP研发费用为33百万美元，较2024年同期的22百万美元上升50.0%[56] - 2025年第三季度非GAAP研发费用为20百万美元，较2024年同期的22百万美元下降9.1%[56]

Exhibit 99.1 Indivior Reports Third Quarter 2025 Financial Results and Raises Full-Year 2025 Financial Guidance • Q3'25 Total Net Revenue of $314m, up 2% YOY; Q3'25 SUBLOCADE® Net Revenue of $219m, up 15% YOY • Conference Call Scheduled for Today at 8:00 A.M. Eastern Richmond, VA, October 30, 2025 – Indivior PLC (Nasdaq: INDV) today reported its financial results for the third quarter ended September 30, 2025, and provided a business update. "In the third quarter, we executed on Phase I of the Indivior Acti ...